Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock (CYCCP) Dividend History

200 Connell Drive, Berkeley Heights, NJ, 07922
Phone: 908-517-7330
Website: https://cyclacel.com

Dividend History

Pay Date	Amount	Ex Dividend Date	Record Date
August 01, 2025	$0.15	07/21/2025	07/21/2025
May 01, 2025	$0.15	04/29/2025	04/29/2025
February 01, 2024	$0.15	01/19/2024	01/22/2024
November 01, 2023	$0.15	10/19/2023	10/20/2023
August 01, 2023	$0.15	07/20/2023	07/21/2023
May 01, 2023	$0.15	04/20/2023	04/21/2023
February 01, 2023	$0.15	01/12/2023	01/13/2023
November 01, 2022	$0.15	10/13/2022	10/14/2022
August 01, 2022	$0.15	07/14/2022	07/15/2022
May 01, 2022	$0.15	04/13/2022	04/14/2022
February 01, 2022	$0.15	01/13/2022	01/14/2022
November 01, 2021	$0.15	10/14/2021	10/15/2021
August 01, 2021	$0.15	07/15/2021	07/16/2021
May 01, 2021	$0.15	04/15/2021	04/16/2021
February 01, 2021	$0.15	01/14/2021	01/15/2021
November 01, 2020	$0.15	10/15/2020	10/16/2020
August 01, 2020	$0.15	07/16/2020	07/17/2020
February 01, 2020	$0.15	01/16/2020	01/17/2020
November 01, 2019	$0.15	10/10/2019	10/14/2019
August 01, 2019	$0.15	07/11/2019	07/12/2019
May 01, 2019	$0.15	04/12/2019	04/15/2019
February 01, 2019	$0.15	01/11/2019	01/14/2019
November 01, 2018	$0.15	10/12/2018	10/15/2018
August 01, 2018	$0.15	07/12/2018	07/13/2018
May 01, 2018	$0.15	04/10/2018	04/11/2018
February 01, 2018	$0.15	01/11/2018	01/12/2018
November 01, 2017	$0.15	10/12/2017	10/13/2017
August 01, 2017	$0.15	07/12/2017	07/14/2017
May 01, 2017	$0.15	04/11/2017	04/14/2017
February 01, 2017	$0.15	01/13/2017	01/18/2017
November 01, 2016	$0.15	10/13/2016	10/17/2016
August 01, 2016	$0.15	07/13/2016	07/15/2016
May 01, 2016	$0.15	04/14/2016	04/18/2016
February 01, 2016	$0.15	01/19/2016	01/21/2016
November 02, 2015	$0.15	10/21/2015	10/23/2015
August 03, 2015	$0.15	07/15/2015	07/17/2015
May 01, 2015	$0.15	04/15/2015	04/17/2015
February 02, 2015	$0.15	12/31/2014	01/05/2015
August 01, 2014	$0.15	06/27/2014	07/01/2014
May 01, 2014	$0.15	04/15/2014	04/18/2014
February 03, 2014	$0.15	01/15/2014	01/17/2014
November 01, 2013	$0.15	10/17/2013	10/21/2013
August 01, 2013	$0.15	07/18/2013	07/22/2013
May 01, 2013	$0.15	04/17/2013	04/19/2013
February 01, 2013	$0.15	01/17/2013	01/22/2013
May 02, 2011	$0.15	04/19/2011	04/22/2011
February 01, 2011	$0.15	01/19/2011	01/21/2011
January 30, 2009	$0.15	01/14/2009	01/19/2009
November 01, 2008	$0.15	10/16/2008	10/20/2008
August 01, 2008	$0.15	07/16/2008	07/18/2008
May 01, 2008	$0.15	04/16/2008	04/18/2008
February 01, 2008	$0.15	01/16/2008	01/18/2008
November 01, 2007	$0.15	10/17/2007	10/19/2007
August 01, 2007	$0.15	07/18/2007	07/20/2007
May 01, 2007	$0.15	04/18/2007	04/20/2007
February 01, 2007	$0.15	01/18/2007	01/22/2007
November 01, 2006	$0.15	10/19/2006	10/23/2006
August 01, 2006	$0.15	07/20/2006	07/24/2006
May 01, 2006	$0.15	04/26/2006	04/29/2006

Dividends Summary

Cyclacel Pharmaceuticals, Inc. 6% Cnvrtbl. Prfrd. Stock has issued 59 dividend payments over the past 19 years
The most recent dividend was paid 37 days ago, on May 1, 2025
The first recorded dividend was paid on May 1, 2006
The highest dividend payout was $0.15 per share
The average dividend over this 19 year span is $0.15 per share

Company News

CYCLACEL PHARMACEUTICALS REPORTS FIRST QUARTER FINANCIAL RESULTS AND PROVIDES BUSINESS UPDATE

Cyclacel Pharmaceuticals announced its Q1 2025 financial results, including a focus on the development of plogosertib and the deconsolidation of its UK subsidiary Cyclacel Limited. The company is exploring strategic alternatives to continue as a going concern, including a share exchange agreement with FITTERS Diversified Berhad.

GlobeNewswire Inc.

Featured Companies: CYCC
Cyclacel Pharmaceuticals Announces Closing of a Change of Control Transaction and Appointment of New Executive Leadership

Cyclacel Pharmaceuticals announced a change in control and leadership, with Datuk Dr. Doris Wong Sing Ee becoming the new CEO and Kiu Cu Seng appointed as Executive Director, Secretary and Chief Financial Officer.

GlobeNewswire Inc.

Featured Companies: CYCC
Cyclacel Pharmaceuticals May Find a Bottom Soon, Here's Why You Should Buy the Stock Now

Cyclacel Pharmaceuticals (CYCC) has seen a downtrend recently, but a hammer chart pattern and strong agreement among analysts on earnings estimates suggest a potential trend reversal. The article recommends buying the stock now.

Benzinga

Featured Companies: CYCC
Cyclacel Announces Notice of Intention to Grant New European Patent Covering Plogosertib Pharmaceutical Compositions

NOTICE OF INTENTION TO GRANT OF NEW EUROPEAN PATENT COVERING PLOGOSERTIB PHARMACEUTICAL COMPOSITIONS - Lengthens Patent Exclusivity to August 2040

GlobeNewswire Inc.

Featured Companies: CYCC
Cyclacel Pharmaceuticals to Release First Quarter 2024 Financial Results

BERKELEY HEIGHTS, N.J., May 08, 2024 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (NASDAQ: CYCC, NASDAQ: CYCCP; "Cyclacel" or the "Company"), a biopharmaceutical company developing innovative medicines based on cancer cell biology, will announce first quarter 2024 financial results on Tuesday, May 14, 2024. The Company will host a conference call and live webcast at 4:30 p.m. Eastern Daylight Time on the same day.

GlobeNewswire Inc.

Featured Companies: CYCC

Dividend data last updated 06/07/2025 22:00:25 UTC